Goldman Sachs’s Arcadia Biosciences RKDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-11,033
| Closed | -$2.99K | – | 5232 |
|
2022
Q4 | $2.99K | Buy |
+11,033
| New | +$2.99K | ﹤0.01% | 5039 |
|
2021
Q3 | – | Sell |
-31,666
| Closed | -$94K | – | 5505 |
|
2021
Q2 | $94K | Buy |
+31,666
| New | +$94K | ﹤0.01% | 5135 |
|
2018
Q1 | – | Sell |
-20,757
| Closed | -$6K | – | 4309 |
|
2017
Q4 | $6K | Buy |
+20,757
| New | +$6K | ﹤0.01% | 4133 |
|
2017
Q3 | – | Sell |
-12,964
| Closed | -$6K | – | 4381 |
|
2017
Q2 | $6K | Sell |
12,964
-196
| -1% | -$91 | ﹤0.01% | 4379 |
|
2017
Q1 | $9K | Sell |
13,160
-2,996
| -19% | -$2.05K | ﹤0.01% | 4372 |
|
2016
Q4 | $15K | Sell |
16,156
-6,634
| -29% | -$6.16K | ﹤0.01% | 4386 |
|
2016
Q3 | $44K | Buy |
22,790
+12,155
| +114% | +$23.5K | ﹤0.01% | 4332 |
|
2016
Q2 | $28K | Sell |
10,635
-4,389
| -29% | -$11.6K | ﹤0.01% | 4357 |
|
2016
Q1 | $42K | Buy |
15,024
+3,084
| +26% | +$8.62K | ﹤0.01% | 4257 |
|
2015
Q4 | $36K | Sell |
11,940
-70,597
| -86% | -$213K | ﹤0.01% | 4264 |
|
2015
Q3 | $252K | Buy |
+82,537
| New | +$252K | ﹤0.01% | 3707 |
|